Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-23-231921
Filing Date
2023-09-11
Accepted
2023-09-11 06:21:58
Documents
4
Period of Report
2023-09-11

Document Format Files

Seq Description Document Type Size
1 6-K d502150d6k.htm 6-K 10146
2 EX-99.1 d502150dex991.htm EX-99.1 36829
3 GRAPHIC g502150g0907193557523.jpg GRAPHIC 2869
4 GRAPHIC g502150g0907194029547.jpg GRAPHIC 3439
  Complete submission text file 0001193125-23-231921.txt   57168
Mailing Address RUE EDOUARD BELIN 12 MONT-SAINT-GUIBERT C9 1435
Business Address RUE EDOUARD BELIN 12 MONT-SAINT-GUIBERT C9 1435 32 10 394 100
Celyad Oncology SA (Filer) CIK: 0001637890 (see all company filings)

EIN.: 000000000 | State of Incorp.: C9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37452 | Film No.: 231246624
SIC: 2834 Pharmaceutical Preparations